Replies to post #13782 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

The price was languishing when the Amgen news came out. It apparently did not leak, which is borderline amazing these days.

[fbg0316]

ADXS has said they are planning to file for conditional approval in Europe this year for cervical cancer based on the Phase 2 data. Clearly when they do so it will be in conjunction with a partner/deal since they will have to have a commercialization plan in place. The question IMO is when is the deal going to be finalized and announced. Hopefully soon, it's tiring seeing the shareholder value erosion and at such a low valuation for a Phase 3 company. What cash does ADXS currently have on the balance sheet? Around $100 million? So factoring out the cash our market value is less than $250 million. Pretty pathetic.